Thermo Fisher Scientific Stock Deutsche Boerse AG
Equities
TN8
US8835561023
Advanced Medical Equipment & Technology
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
537.2 EUR | +0.35% | -1.19% | +12.13% |
Sales 2024 * | 43.02B 39.62B | Sales 2025 * | 46.1B 42.45B | Capitalization | 223B 205B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B 5.66B | Net income 2025 * | 6.97B 6.42B | EV / Sales 2024 * | 5.73 x |
Net Debt 2024 * | 23.49B 21.63B | Net Debt 2025 * | 19.14B 17.62B | EV / Sales 2025 * | 5.25 x |
P/E ratio 2024 * |
36.7
x | P/E ratio 2025 * |
31.5
x | Employees | 122,000 |
Yield 2024 * |
0.26% | Yield 2025 * |
0.28% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | +0.34% | ||
1 week | -1.19% | ||
Current month | -0.19% | ||
1 month | +0.30% | ||
3 months | +3.34% | ||
6 months | +20.37% | ||
Current year | +12.13% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-27 | 539 | +0.67% | 106 |
24-05-24 | 535.4 | -1.64% | 655 |
24-05-23 | 544.3 | -0.89% | 30 |
24-05-22 | 549.2 | +1.72% | 14 |
24-05-21 | 539.9 | -1.03% | 125 |
Delayed Quote Deutsche Boerse AG, May 27, 2024 at 11:42 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.28% | 65.01B | |
+15.38% | 53.02B | |
+3.64% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B | |
+23.97% | 31.33B |
- Stock Market
- Equities
- TMO Stock
- TN8 Stock